Immunotherapy Decision-Making Experiences of Patients With Cancer and Their Family Caregivers: A Qualitative Study.
Yun-Hsiang Lee, Chia-Li Siao, Zi-Xuan Gao and 1 others
PMID 41217436WHAT IT FOUND
Patients and caregivers described trusting doctors, valuing life over cost, and choosing immunotherapy because chemotherapy side effects, financial limits, and expected benefits shaped decisions.
Nurses can support education, side-effect concerns, and financial navigation.
Key findings
01Patients and caregivers described putting decisions in the hands of health professionals, valuing life over other considerations, and weighing practical issues such as side effects, financial burden, and immunotherapy effects.
02Seven patients (47%) and six caregivers (35%) reported a lack of medical knowledge that made it hard to follow health care advice.
03Seven caregivers chose immunotherapy because they could not bear the side effects of existing treatment.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was done in one hospital in northern Taiwan, so findings may not transfer to other countries or health systems. Most patient participants were male (80%), so female patients' experiences may be underrepresented. It reports interview themes, not treatment outcomes, so it cannot show whether immunotherapy worked or whether nurse education changed decisions. Patients with mental disorders or unable to communicate effectively were excluded, so people with severe distress or communication difficulties may not be represented.
Declared interests
The paper reports funding by the National Science and Technology Council.
The easy way to misread this
Do not read these themes as evidence that immunotherapy works or that patient education changes outcomes. The study reports patients' and caregivers' experiences, not treatment effects.